rewirebio.iobenchmarks
Source

Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system

2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied · Peer-reviewed

DOI: 10.1016/j.gimo.2024.101961Original source

What this source contributed

Records in this release that cite this source. A record can cite several sources.

Results

Values as the source printed them. Compare results only under compatible protocols, datasets and metrics.

Claims

Statements this source supports, each with where in the source it was checked.

Models, benchmarks and other records

Configurations (2)

Benchmarks (1)

Protocols (2)

Datasets (1)

Evaluations (2)

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

16 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-adc15377fab2
Property and statementOriginal source and locationReview and provenance
Artifact retrieved at
2026-10-05T14:02:27Z
Source metadata
Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system

Original source ↗

No field-specific location recorded

Version: 2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
Retrieved: 2026-10-05T14:02:27Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.artifact_retrieved_at

Source artifact SHA-256: 2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Artifact SHA-256
2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb
Source metadata
Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system

Original source ↗

No field-specific location recorded

Version: 2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
Retrieved: 2026-10-05T14:02:27Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.artifact_sha256

Source artifact SHA-256: 2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Artifact url
https://pmc.ncbi.nlm.nih.gov/articles/PMC11869971/
Source metadata
Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system

Original source ↗

No field-specific location recorded

Version: 2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
Retrieved: 2026-10-05T14:02:27Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.artifact_url

Source artifact SHA-256: 2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Doi
10.1016/j.gimo.2024.101961
Source metadata
Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system

Original source ↗

No field-specific location recorded

Version: 2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
Retrieved: 2026-10-05T14:02:27Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.doi

Source artifact SHA-256: 2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Publication status
peer_reviewed
Source metadata
Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system

Original source ↗

No field-specific location recorded

Version: 2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
Retrieved: 2026-10-05T14:02:27Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.publication_status

Source artifact SHA-256: 2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Retrieved at
2026-10-05T14:02:27Z
Source metadata
Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system

Original source ↗

No field-specific location recorded

Version: 2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
Retrieved: 2026-10-05T14:02:27Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.retrieved_at

Source artifact SHA-256: 2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Url
https://pmc.ncbi.nlm.nih.gov/articles/PMC11869971/
Source metadata
Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system

Original source ↗

No field-specific location recorded

Version: 2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
Retrieved: 2026-10-05T14:02:27Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.url

Source artifact SHA-256: 2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Version
2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
Source metadata
Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system

Original source ↗

No field-specific location recorded

Version: 2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
Retrieved: 2026-10-05T14:02:27Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.version

Source artifact SHA-256: 2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Description
Primary source inspected for the scoped extraction; automated review does not establish replication.
Source metadata
Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system

Original source ↗

No field-specific location recorded

Version: 2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
Retrieved: 2026-10-05T14:02:27Z

catalogued

No individual claim review recorded

Audit details

Field: description

Source artifact SHA-256: 2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Facets: areas
1 values
  • dna-genomes
Source metadata
Reclassification of VUS in BRCA1 and BRCA2 using the new BRCA1/BRCA2 ENIGMA track set demonstrates the superiority of ClinGen ENIGMA Expert Panel specifications over the standard ACMG/AMP classification system

Original source ↗

No field-specific location recorded

Version: 2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
Retrieved: 2026-10-05T14:02:27Z

catalogued

No individual claim review recorded

Audit details

Field: facets.areas

Source artifact SHA-256: 2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-21-adc15377fab2 · Record review: source checked

Primary source inspected for the scoped extraction; automated review does not establish replication.

Release history

No supporting source is linked yet.

Read original source

Download this release (gzip)
Technical metadata and extraction receipts

Stable ID: uc-clinical-20261005-source-benet-pages

areas
dna-genomes
contexts
clinical_research
url
https://pmc.ncbi.nlm.nih.gov/articles/PMC11869971/
retrieved at
2026-10-05T14:02:27Z
version
2025 published article (Genetics in Medicine Open); ENIGMA BRCA1/BRCA2 VCEP specification v1.1.0 applied
publication status
peer_reviewed
doi
10.1016/j.gimo.2024.101961
artifact sha256
2e458cacad35cca0507753c43c5104b75217593a0c2fdbd16143f0391fba33eb
artifact url
https://pmc.ncbi.nlm.nih.gov/articles/PMC11869971/
artifact retrieved at
2026-10-05T14:02:27Z
Related records

    Suggest a correction